BERNARDINO
ALCÁZAR NAVARRETE
PROFESOR ASOCIADO CIENCIAS SALUD
Francisco
García Río
Publicaciones en las que colabora con Francisco García Río (8)
2022
-
[Translated article] Biological Biomarkers in Respiratory Diseases
Archivos de Bronconeumologia
2021
-
Burden of disease among exacerbating patients with COPD treated with triple therapy in Spain
International Journal of COPD, Vol. 16, pp. 2149-2161
2019
-
Correction: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: A Spanish National Healthcare System perspective (Respiratory Research (2018) 19 (224) DOI: 10.1186/s12931-018-0916-7)
Respiratory Research
-
Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care
Archivos de Bronconeumologia, Vol. 55, Núm. 9, pp. 478-487
2018
-
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: A Spanish National Healthcare System perspective
Respiratory Research, Vol. 19, Núm. 1
-
Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus
Pulmonary Pharmacology and Therapeutics, Vol. 48, pp. 97-103
2017
-
Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus
COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 14, Núm. 6, pp. 573-580
2014
-
Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems
Health and Quality of Life Outcomes, Vol. 12, Núm. 1